Study of Chitosan for Pharmacologic Manipulation of AGE Levels in Prostate Cancer Patients

NCT03712371 PHASE1, PHASE2 TERMINATED Results posted

This study will examine the utility of chitosan for reduction of blood or tissue levels of AGEs in patients with prostate cancer who are clinically stable on androgen-deprivation therapy.

Details

Lead sponsor	Medical University of South Carolina
Phase	PHASE1, PHASE2
Status	TERMINATED
Enrolment	12
Start date	Wed Jan 16 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Tue Sep 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Prostate Cancer

Interventions

• Chitosan

Countries

United States